Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,287
Total Claims
$651K
Drug Cost
409
Beneficiaries
$1,592
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
+4%
Cost per patient vs peers
$1,592 vs $1,524 avg
-9%
Brand preference vs peers
12.4% vs 13.7% avg
Brand vs Generic
Brand: 1,635 claims · $529K
Generic: 11,565 claims · $119K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 185 | $116K |
| Apixaban | 166 | $105K |
| Rivaroxaban | 122 | $69K |
| Dapagliflozin Propanediol | 60 | $35K |
| Sitagliptin Phos/Metformin Hcl | 50 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 75 | $27K |
| Sitagliptin Phosphate | 43 | $26K |
| Levothyroxine Sodium | 484 | $24K |
| Candesartan Cilexetil | 318 | $18K |
| Insulin Lispro | 27 | $12K |
| Atorvastatin Calcium | 1,516 | $11K |
| Insulin Lispro Protamin/Lispro | 14 | $11K |
| Metoprolol Succinate | 858 | $11K |
| Linagliptin | 19 | $10K |
| Ticagrelor | 15 | $7,816 |
Prescribing Profile
Patient Profile
72
Avg Age
55%
Female
1.76
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data